What is GAMMAGARD LIQUID
GAMMAGARD LIQUID IV is an infusion that is administered into a vein. Patients with Primary Immunodeficiency (PI) will typically receive IV infusions every 3 or 4 weeks. The IV infusions may be given in a hospital, an infusion center, or at home by a nurse.
Sustained protection against infection
In the IV administration clinical study of 61 patients with PI, GAMMAGARD LIQUID was shown to be effective at a dose of 300 to 600 mg/kg every 3 to 4 weeks for 12 months.
There were no cases of validated acute serious bacterial infections (ASBIs)
No patients were hospitalized
due to infection
There were 4 occurrences of validated other bacterial infections reported*
*The validated other bacterial infections were urinary tract infection (1), gastroenteritis (sometimes called “stomach flu”) (1), and ear infection (2)
In a total of 1,812 infusions in the clinical study, the most common side effect for GAMMAGARD LIQUID IV was headache (5.2%).
The most common side effects (seen in ≥5% of patients) were headache, fatigue, fever, nausea, chills/shaking chills, pain in the hands or feet, diarrhea, migraine, dizziness, vomiting, cough, hives, asthma, sore throat, rash, joint pain, muscle pain, swelling in the arms or legs, itching, and heart murmur. Learn more about GAMMAGARD LIQUID’s safety and side effects.
considered mild to moderate
95% of the 400 side effects reported in this study were
considered mild (217) to moderate (164). The remaining 5% (19)
Please click here for more details about GAMMAGARD LIQUID's side effects and safety information.
What would help you feel truly cared for? GAMMAGARD LIQUID offers options, so you and your doctor can create an infusion experience that's right for you.Explore your options
Safety and side effects
When you—or someone you love—starts a new treatment, discussing safety is one of the most important conversations you can have with your doctor.Learn about safety